Myovant Sciences Ltd. Forms 3, 4 and 5: Stock Options, 2016

Myovant Sciences Ltd. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2016-11-15: Reporting owner Curran Terrie; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
2016-10-26: Reporting owner Sebelius Kathleen; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
2016-10-26: Reporting owner DeVeydt Wayne S; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
2016-10-26: Reporting owner Altmeyer Mark; Form 3; Security Stock Option (Right to Buy); Transaction Holding.

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2016-11-15	Curran Terrie Director	4	Stock Option (Right to Buy) Derivative · Direct	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+33,846 33,846 owned after	$11.30 exercise price	2016-11-17
2016-10-26 holding as of filing	Sebelius Kathleen Director	3	Stock Option (Right to Buy) Derivative · Direct	Holding		$5.11 exercise price	2016-10-26
2016-10-26 holding as of filing	DeVeydt Wayne S Director	3	Stock Option (Right to Buy) Derivative · Direct	Holding		$5.11 exercise price	2016-10-26
2016-10-26 holding as of filing	Altmeyer Mark Director	3	Stock Option (Right to Buy) Derivative · Direct	Holding		$5.11 exercise price	2016-10-26
2016-10-26 holding as of filing	Romeo Marianne L. Officer (Head,Global Trans. & Risk Mgmt)	3	Employee Stock Option (Right to Buy) Derivative · Direct	Holding		$2.42 exercise price	2016-10-26
2016-10-26 holding as of filing	KARBE FRANK Officer (Principal Fin'l & Accounting)	3	Employee Stock Option (Right to Buy) Derivative · Direct	Holding		$5.11 exercise price	2016-10-26